<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01340963</url>
  </required_header>
  <id_info>
    <org_study_id>012345/96</org_study_id>
    <nct_id>NCT01340963</nct_id>
  </id_info>
  <brief_title>The Signal-averaged ElectrocArdiogram in Long Term Follow-up of Chronic CHagas Disease - RIO de Janeiro Cohort</brief_title>
  <acronym>SEARCH-Rio</acronym>
  <official_title>Prognostic Value of the Spectral Turbulence Analysis of the Signal-averaged Electrocardiogram in Chagas Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Gama Filho</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rio de Janeiro State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Instituto Nacional de Cardiologia de Laranjeiras</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidade Gama Filho</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study investigated 100 subjects, both genders, with chronic Chagas disease, confirmed by&#xD;
      at least two distinct serological tests, and classified according to Los Andes classification&#xD;
      in a long term follow-up aiming at identifying the predictive value of the signal-averaged&#xD;
      electrocardiogram for cardiac death and ventricular tachycardia.&#xD;
&#xD;
      All subjects admitted to the study were submitted to clinical history taking, physical&#xD;
      examination, and noninvasive assessment, including blood pressure measurement, resting&#xD;
      12-lead surface electrocardiogram, 24h ambulatory electrocardiogram monitoring,&#xD;
      M-Mode/two-dimensional echocardiogram, signal-averaged electrocardiogram in both time and&#xD;
      frequency domains. Selected subjects were further submitted to treadmill stress test and&#xD;
      coronary angiography to rule out coronary heart disease.&#xD;
&#xD;
      Subjects were followed by non-investigational primary care assistance at three to six months&#xD;
      scheduled clinical visits on an outpatients basis. Both noninvasive and invasive evaluation&#xD;
      during follow-up were requested at discretion of primary evaluation. Adverse outcomes were&#xD;
      ascertained by review of medical records and active contact to either study subjects or their&#xD;
      relatives.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Admission:&#xD;
&#xD;
      Longitudinal prospective study, with a cohort of 100 consecutive outpatient subjects (34 to&#xD;
      74 years old; 31 females) with Chagas' disease followed-up for at least 10 years at the&#xD;
      cardiomyopathy outpatient clinic of University Hospital, Rio de Janeiro, RJ, Brazil, a&#xD;
      tertiary care center. Enrollment was from 1995 to 1999. Subjects were born in endemic regions&#xD;
      of Minas Gerais, Goias or Bahia States of Brazil and Chagas' disease was diagnosed on basis&#xD;
      of two positive serum tests, hemagglutination cruzipain-ELISA and indirect&#xD;
      immunofluorescence. All subjects were referred to the arrhythmia for risk stratification. At&#xD;
      the time of admission none had received nitroderivative therapy. Subjects were classified&#xD;
      according to the severity of heart involvement according to Los Andes classification, and&#xD;
      divided into three groups: class I - 28 subjects (group 1), class II - 48 subjects (group 2),&#xD;
      and class III - 24 subjects (group 3). Clinical and laboratory data were assessed during a&#xD;
      personal interview and review of medical records. On admission, all subjects were in New York&#xD;
      Heart Association functional class I or II, had normal sinus rhythm and normal PR intervals.&#xD;
      Exclusion criteria at initial enrollment were: any degree of atrioventricular block or&#xD;
      non-sinus rhythm, previous documented acute coronary events (unstable angina or myocardial&#xD;
      infarction), chronic obstructive pulmonary disease, rheumatic valvular heart disease, alcohol&#xD;
      addiction, thyroid dysfunction or abnormal serum electrolytes. Treadmill stress test and/or&#xD;
      coronary artery angiogram were indicated in selected subjects to rule out concomitant&#xD;
      coronary artery disease. World Health Organization and Helsinki Treaty regulations reviewed&#xD;
      in Venice (1983) were followed and all subjects provided informed consent to participate.&#xD;
&#xD;
      Clinical follow-up:&#xD;
&#xD;
      All subjects have been followed-up by the same team of physicians. Medical visits have been&#xD;
      scheduled at the outpatient clinics in a three to six-month interval. Medications were&#xD;
      prescribed at the discretion of the physician who performed the primary evaluation. Body&#xD;
      weight varied &lt;2 kg during follow-up, and serum potassium varied from 3.5 to 5&#xD;
      milliequivalent/L. Mild systemic arterial hypertension (systolic arterial pressure ranging&#xD;
      from 140 mmHg and 155 mmHg, or diastolic arterial pressure ranging from 90 mmHg and 105 mmHg)&#xD;
      was observed in 41% of the subjects and all received anti-hypertensive medication (converting&#xD;
      enzyme inhibitors, diuretics, vasodilators and/or beta-blockers) at the discretion of the&#xD;
      physician who performed the primary evaluation in order to reduce blood pressure levels to&#xD;
      less than 140/90 mmHg. All regularly followed at scheduled clinical visits. The endpoints&#xD;
      were described elsewhere in this registry. All causes of adverse events were ascertained by&#xD;
      active search of relatives and review of the medical records.&#xD;
&#xD;
      Resting surface 12-lead ECG and plain chest roentgenogram&#xD;
&#xD;
      For each patient, standard resting 12-lead ECGs were recorded in the supine position (with&#xD;
      simultaneous 3-lead acquisition) with a Cardimax ECAPS 12 2000 Compliant Electrocardiograph&#xD;
      (Nihon-Kohden Co, Tokyo, Japan). Electrocardiographic abnormalities were classified according&#xD;
      to standard criteria for conduction disturbances (intraventricular and atrioventricular),&#xD;
      chamber overload, and abnormal Q waves [11]. The electrocardiographic variables assessed is&#xD;
      sinus rhythm were: maximum P-wave duration and PR interval (typically in lead II), QRS&#xD;
      complex duration (the longest ventricular duration in precordial leads), maximal absolute QRS&#xD;
      complex in any precordial lead, presence of bundle branch block and/or left fascicular-block,&#xD;
      presence of abnormal Q waves (Q-wave, defined as the first QRS deflection &gt;1-mm deep and&#xD;
      &gt;0.04-ms wide), and left atrial overload (P-wave duration in lead II &gt;110 ms or Morris index&#xD;
      in V1 &gt;4 millivolt.ms). In antero-septal leads (V1, V2 and V3) and in inferior leads (L2, L3&#xD;
      and aVF) the presence of Q-wave in two out of three leads was considered abnormal. An&#xD;
      independent observer blind to the study analyzed the electrocardiographic records that were&#xD;
      automatically obtained from electrocardiograph equipment. Subsequent 12-lead resting ECGs&#xD;
      were recorded at each clinical visit in order to assess cardiac rhythm during follow-up.&#xD;
      Plain chest roentgenogram was carried out on the same day and cardiomegaly was defined by a&#xD;
      cardiothoracic ratio of more than 0.50.&#xD;
&#xD;
      M-mode/2-D Echocardiogram&#xD;
&#xD;
      M-mode and two-dimensional echocardiograms were performed using an Apogee CX-200 equipment&#xD;
      (ATL, Bothell, Washington, USA) with a 4-megahertz broadband transducer. The echocardiograms&#xD;
      were analyzed by a trained observer blinded to the study protocol Echocardiographic&#xD;
      parameters were assessed according to standard procedures of the Section of Echocardiography&#xD;
      of the Department of Cardiology, with special care taken to detect left ventricular apical&#xD;
      aneurysms. The echocardiographic parameters assessed were left ventricular ejection fraction&#xD;
      (LVEF) calculated by the teichholz method, left atrial diameter (LAD), presence of pulmonary&#xD;
      arterial hypertension (defined as maximal pulmonary arterial pressure &gt; 30 mmHg, diastolic&#xD;
      dysfunction, and the presence of an apical aneurysm. Normal cut-off value for LVEF was&#xD;
      defined as &gt;50%. Routine echocardiograms were performed in order to track changes in LVEF&#xD;
      during follow-up.&#xD;
&#xD;
      24h Ambulatory ECG Monitoring&#xD;
&#xD;
      Twenty-four-hour ambulatory ECG monitoring was performed using a three-channel&#xD;
      DMS-cassette-tape recorder and carefully analyzed using the Del-Mar Avionics StrataScan&#xD;
      System (Del Mar Avionics, Irvine, California, USA) by a trained observer blind to the study&#xD;
      in order to assess the presence of ventricular arrhythmia and atrioventricular conduction&#xD;
      disturbances. Variables assessed in the 24h ambulatory ECG were: i) isolated premature&#xD;
      supraventricular contractions ii) nonsustained supraventricular tachycardia defined as a&#xD;
      sequence of three of more supraventricular ectopic beats, iii) isolated premature ventricular&#xD;
      contractions, and iv) ventricular tachycardia episodes (defined as: heart rate &gt;100 bpm, QRS&#xD;
      duration &gt;120 ms, three or more consecutive ventricular complexes, and atrial-ventricular&#xD;
      dissociation).&#xD;
&#xD;
      The standard-deviation of all consecutive normal interbeat intervals in 24h (24h SDNN) was&#xD;
      employed to assess heart rate variability. Normal cut-off point was defined at &gt;=100ms.&#xD;
      During follow-up, 24h ambulatory ECG were performed at the discretion of attending&#xD;
      physician's judgment in order to assess cardiac rhythm and arrhythmia. One trained specialist&#xD;
      blind to Los Andes classification groups analyzed all tape recordings immediately after their&#xD;
      acquisition.&#xD;
&#xD;
      Signal-averaged electrocardiogram&#xD;
&#xD;
      Signal-averaged electrocardiogram (SAECG) was employed to asses the presence of both&#xD;
      ventricular late potentials and intraventricular electrical transients (IVET).&#xD;
&#xD;
      SAECG was acquired in sinus rhythm with a Predictor-IIc equipment (ART Inc., Fitchburg,&#xD;
      Massachusetts, USA) using modified XYZ Frank orthogonal leads and QRS-triggered&#xD;
      coherent-averaged up to the noise level of 0.3 microvolt. SAECGs were analyzed in both time&#xD;
      and frequency domains by an independent observer blinded to the study patients information.&#xD;
      After signal average ECG acquisition, time domain analysis was carried out on vector&#xD;
      magnitude (VM), using a bidirectional 4th order 40 Hz to 250 Hz band-pass Butterworth filter.&#xD;
      The variables extracted from VM were: duration of VM (DUR [ms]), root-mean-squared voltage of&#xD;
      last 40ms of VM (RMS40[microvolt]) duration of potentials below 40 microvolt at the terminal&#xD;
      portion of VM (LAS40[ms]). Due to the presence of bundle branch block as a common finding in&#xD;
      Chagas disease, normal cut-off point for DUR was defined at &gt;150ms.&#xD;
&#xD;
      The onset and offset points of VM delimited the analytic region for frequency domain&#xD;
      analysis, by using the spectral turbulence analysis approach. The analytic region in VM was&#xD;
      preprocessed to extract the first derivative, aiming at removing the high-amplitude&#xD;
      low-frequency components. The derived signal was cut into slices to build a power spectral&#xD;
      density time-frequency map by applying the short-time Fourier transform. Each data segment&#xD;
      was limited in 25 ms, with 2 ms interval between successive segments to assure adequate&#xD;
      time-resolution, tapered by a Blackmann-Harris window after mean removal, and zero-padded to&#xD;
      64 points. After Fourier transform of a particular segment, its spectral amplitude was&#xD;
      squared to obtain the estimated power spectral density function. Successive power spectral&#xD;
      density function estimates in the analytic region were attached in a three-dimensional map.&#xD;
      The boundaries of the analytic region (up to 200 ms duration) were placed 25 ms prior to the&#xD;
      onset of the VM and to a point on the ST segment 50 ms after the offset of the VM. In the&#xD;
      time frequency map, spectral turbulence was studied by comparing sequential spectral&#xD;
      estimates. We calculated Pearson's correlation coefficient between adjacent power spectral&#xD;
      function estimates throughout ventricular activation, and deployed the correlation&#xD;
      coefficients in a time series, of which the mean and the standard deviation of the&#xD;
      intersegment spectral correlation (abbreviated as MSC and SSC, respectively) were calculated.&#xD;
      Additionally, we calculated the frequency corresponding to 80% of the total area under a&#xD;
      particular power spectral function estimate, starting at zero Hz, which practically&#xD;
      represented the edge or the border, and deployed the edge frequency, thus calculated, in a&#xD;
      time series. The mean and the standard deviation of the electrical transients (abbreviated as&#xD;
      MET and SET, respectively) of the edge frequency series were extracted. Power spectral&#xD;
      estimates were limited to the range from 0 to 300 Hz in order to avoid interference of high&#xD;
      frequency noise during correlation. MSC and SSC were multiplied by 100 to simplify&#xD;
      calculations. Normality threshold values have been defined previously as MSC&gt;94, SSC&lt;=6,&#xD;
      MET&lt;=78 and The SET&lt;=31. The presence of intraventricular electrical transients (IVET+) was&#xD;
      optimally defined when 2 out of 4 variables were outside normality range. We used the above&#xD;
      method based on our hypothesis that the presence of high frequency electrical transients,&#xD;
      representing underlying electrically unstable myocardial areas, would determine the reduction&#xD;
      of intersegment correlation. Likewise, high frequency transients would increase the energy&#xD;
      content of a spectral estimate and the shift the spectral border rightward, to a higher&#xD;
      frequency.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 1995</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">March 2001</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac death [Time Frame: up to 10 years ]</measure>
    <time_frame>up tp 10 years</time_frame>
    <description>Defined as intractable heart failure, arrhythmic, coronary occlusion, or sudden death.&#xD;
Assessment twice an year by active and direct contact to subjects or relatives and review of medical records.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ventricular tachycardia</measure>
    <time_frame>up to ten years</time_frame>
    <description>New onset ventricular tachycardia defined as symptomatic (palpitations, dizziness or syncope), &gt;=3 consecutive beats, bundle branch block configuration, ventricular rate &gt;100bpm, atrial-ventricular dissociation.&#xD;
Assessed with 24h-ambulatory electrocardiogram monitoring requested at discretion of non-investigational primary evaluation and confirmed by review of medical records.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke, either fatal or nonfatal</measure>
    <time_frame>up to 10 years</time_frame>
    <description>Evidence of clinically definite stroke (focal neurological deficits persisting for more than 24 hours) confirmed or not by non-investigational CT.&#xD;
Assessment twice an year by active and direct contact to patents or relatives and review of medical records.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent atrial fibrillation</measure>
    <time_frame>up to 10 years</time_frame>
    <description>Irregular non-sinus interbeat interval, lasting more that 24h, confirmed by either non-investigational 24h ambulatory electrocardiogram monitoring or resting 12-lead surface electrocardiogram two to four times a year.&#xD;
Assessment by review of medical records.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac function and dimensions</measure>
    <time_frame>up to 10 years</time_frame>
    <description>Non-investigational M-mode/2-D echocardiographic evaluation at the discretion of primary care assistance.&#xD;
Assessment by review of medical records.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Chagas Cardiomyopathy</condition>
  <condition>Cardiac Arrhythmia</condition>
  <condition>Stroke</condition>
  <condition>Left Ventricular Function Systolic Dysfunction</condition>
  <condition>Cardiac Death</condition>
  <arm_group>
    <arm_group_label>Class I</arm_group_label>
    <description>Structurally normal heart, no bundle branch block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Class II</arm_group_label>
    <description>Mild symptoms, bundle brunch block or hemi-block on resting surface electrocardiogram, normal cardiac silhouette on plain chest X-ray film, left ventricular diastolic dysfunction as relaxation deficit (type I), none or mild global left ventricular systolic dysfunction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Class III</arm_group_label>
    <description>Overtly symptomatic, enlarged cardiac silhouette on plain chest X-ray film, left ventricular diastolic dysfunction, global systolic dysfunction, ventricular tachycardia, atrio-ventricular block (any degree)</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        One hundred clinically stable subjects with at least 10 years of regular outpatients&#xD;
        follow-up and positive epidemiological history and serological confirmation of Chagas&#xD;
        disease with ate least two immunological tests.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinically stable outpatients with at least 10 years of regular outpatients follow-up&#xD;
             and positive epidemiological history and serological confirmation of Chagas disease&#xD;
             with ate least two immunological tests&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any degree of atrioventricular block or non-sinus rhythm&#xD;
&#xD;
          -  Previous documented acute coronary events (due to documented obstructive epicardial&#xD;
             coronary vessels)&#xD;
&#xD;
          -  Chronic obstructive pulmonary disease&#xD;
&#xD;
          -  Rheumatic valvular heart disease&#xD;
&#xD;
          -  Alcohol addiction&#xD;
&#xD;
          -  Thyroid dysfunction&#xD;
&#xD;
          -  Abnormal serum electrolytes and biochemical abnormalities&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paulo R Benchimol-Barbosa, MD, DSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rio de Janeiro State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universit√°rio Pedro Ernesto</name>
      <address>
        <city>Rio de Janeiro</city>
        <state>RJ</state>
        <zip>20551-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universidade Gama Filho</name>
      <address>
        <city>Rio de Janeiro</city>
        <state>RJ</state>
        <zip>20740-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Nacional de Cardiologia</name>
      <address>
        <city>Rio de Janeiro</city>
        <state>RJ</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Benchimol-Barbosa PR, Nasario-Junior O, Nadal J. The effect of configuration parameters of time-frequency maps in the detection of intra-QRS electrical transients of the signal-averaged electrocardiogram: impact in clinical diagnostic performance. Int J Cardiol. 2010 Nov 5;145(1):59-61. doi: 10.1016/j.ijcard.2009.04.013. Epub 2009 May 9.</citation>
    <PMID>19428130</PMID>
  </reference>
  <reference>
    <citation>Benchimol-Barbosa PR, Muniz RT. Ventricular late potential duration correlates to the time of onset of electrical transients during ventricular activation in subjects post-acute myocardial infarction. Int J Cardiol. 2008 Sep 26;129(2):285-7. Epub 2007 Aug 10.</citation>
    <PMID>17692944</PMID>
  </reference>
  <reference>
    <citation>Benchimol-Barbosa PR. Trends on acute Chagas' disease transmitted by oral route in Brazil: steady increase in new cases and a concealed residual fluctuation. Int J Cardiol. 2010 Dec 3;145(3):494-6. doi: 10.1016/j.ijcard.2009.08.030. Epub 2009 Sep 16.</citation>
    <PMID>19762096</PMID>
  </reference>
  <results_reference>
    <citation>Benchimol-Barbosa PR, Barbosa-Filho J. Mechanical cardiac remodeling and new-onset atrial fibrillation in long-term follow-up of subjects with chronic Chagas' disease. Braz J Med Biol Res. 2009 Mar;42(3):251-62.</citation>
    <PMID>19287904</PMID>
  </results_reference>
  <results_reference>
    <citation>Benchimol-Barbosa PR. Predictors of mortality in Chagas' disease: the impact of atrial fibrillation and oral transmission on infected population. Int J Cardiol. 2009 Apr 3;133(2):275-7. doi: 10.1016/j.ijcard.2007.11.053. Epub 2008 Jan 15.</citation>
    <PMID>18199497</PMID>
  </results_reference>
  <results_reference>
    <citation>Benchimol-Barbosa PR. Cardiac remodeling and predictors for cardiac death in long-term follow-up of subjects with chronic Chagas' heart disease: a mathematical model for progression of myocardial damage. Int J Cardiol. 2009 Jan 24;131(3):435-8. Epub 2007 Nov 28.</citation>
    <PMID>18053595</PMID>
  </results_reference>
  <results_reference>
    <citation>Benchimol-Barbosa PR, Barbosa-Filho J. Atrial mechanical remodeling and new onset atrial fibrillation in chronic Chagas' heart disease. Int J Cardiol. 2008 Jul 21;127(3):e113-5. Epub 2007 Aug 8.</citation>
    <PMID>17689724</PMID>
  </results_reference>
  <results_reference>
    <citation>Benchimol-Barbosa PR. Nonlinear mathematical model for predicting long term cardiac remodeling in Chagas' heart disease: introducing the concepts of 'limiting cardiac function' and 'cardiac function deterioration period'. Int J Cardiol. 2010 Nov 19;145(2):219-221. doi: 10.1016/j.ijcard.2009.05.010. Epub 2009 May 27.</citation>
    <PMID>19477538</PMID>
  </results_reference>
  <results_reference>
    <citation>Benchimol-Barbosa PR, Kantharia BK, Carvalhaes CG. Nonlinear Dynamics in Long-Term Left Ventricular Remodeling in Chagas Heart Disease and Adverse Outcomes: SEARCH-Rio Substudy. Circulation Research. 2012;111:A351</citation>
  </results_reference>
  <results_reference>
    <citation>Benchimol-Barbosa PR, Tura BR, Barbosa E, Barbosa-Filho J, Kantharia BK. A Novel Risk Score Based on Noninvasive ECG Monitoring Aiming at Predicting Ventricular Tachycardia and Cardiac Death in Chronic Chagas Disease. Circulation. 2010; 122: A19759.</citation>
  </results_reference>
  <results_reference>
    <citation>Benchimol Barbosa PR. Noninvasive prognostic markers for cardiac death and ventricular arrhythmia in long-term follow-up of subjects with chronic Chagas' disease. Braz J Med Biol Res. 2007 Feb;40(2):167-78.</citation>
    <PMID>17273653</PMID>
  </results_reference>
  <results_reference>
    <citation>Benchimol-Barbosa PR, Duque GS, Barbosa-Filho J. Long term cardiac remodelling in chronic Chagas' heart disease. Eur Heart J; 2008. 29(suppl 1): 441-441. doi:10.1093/eurheartj/ehn375</citation>
  </results_reference>
  <results_reference>
    <citation>Benchimol-Barbosa PR, Duque GS, Barbosa EC, Bomfim AS, Dantas-Carletti MS, Barbosa-Filho J. High spectral turbulence in signal-averaged electrocardiogram is an independent predictor for cardiac death in long-term follow-up of subjects with chronic Chagas disease. Eur Heart J; 2009. 30(suppl 1): 697-697. doi:10.1093/eurheartj/ehp415</citation>
  </results_reference>
  <results_reference>
    <citation>Benchimol-Barbosa PR, Tura BR, Barbosa EC, Barbosa-Filho J, Kantharia BK. A novel risk score for predicting cardiac death in chronic chagas heart disease based on spectral turbulence analysis of the signal-averaged ECG. Eur Heart J; 2010. 31(suppl 1): 163-163. doi:10.1093/eurheartj/ehq287</citation>
  </results_reference>
  <results_reference>
    <citation>Benchimol-Barbosa PR, Tura BR, Barbosa-Filho J, Kantharia BK. Increasing 24h incidence of isolated PVC is associated with growing complexity and incidence of cardiac tachyarrhythmia in Chagas heart disease. Eur Heart J; 2010. 31(suppl 1): 480-480. doi:10.1093/eurheartj/ehq288</citation>
  </results_reference>
  <results_reference>
    <citation>Benchimol-Barbosa PR. Clinical characteristics of spontaneous ventricular tachycardia episodes associated with unfavorable prognosis in chronic Chagas disease. Eur Heart J; 2010. 31(suppl 1): 480-480. doi:10.1093/eurheartj/ehq288</citation>
  </results_reference>
  <results_reference>
    <citation>PR Benchimol-Barbosa. Ventricular tachyarrhythmic events triggers in chronic Chagas disease. Eur Heart J; 2010. 31(suppl 1): 481-481. doi:10.1093/eurheartj/ehq288</citation>
  </results_reference>
  <results_reference>
    <citation>Benchimol-Barbosa PR, Tura BR, Barbosa EC, Kantharia BK. Utility of a novel risk score for prediction of ventricular tachycardia and cardiac death in chronic Chagas disease - the SEARCH-RIO study. Braz J Med Biol Res. 2013 Nov;46(11):974-984. Epub 2013 Oct 22.</citation>
    <PMID>24270912</PMID>
  </results_reference>
  <verification_date>December 2013</verification_date>
  <study_first_submitted>April 21, 2011</study_first_submitted>
  <study_first_submitted_qc>April 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 25, 2011</study_first_posted>
  <last_update_submitted>December 9, 2013</last_update_submitted>
  <last_update_submitted_qc>December 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Gama Filho</investigator_affiliation>
    <investigator_full_name>Paulo Roberto Benchimol Barbosa</investigator_full_name>
    <investigator_title>Head Researcher</investigator_title>
  </responsible_party>
  <keyword>Chagas heart disease</keyword>
  <keyword>ventricular tachycardia</keyword>
  <keyword>atrial fibrillation</keyword>
  <keyword>stroke</keyword>
  <keyword>cardiac death</keyword>
  <keyword>signal averaged electrocardiogram</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chagas Cardiomyopathy</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
    <mesh_term>Death</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

